1. Bringing Global Innovation to China
China compresses time. What takes years elsewhere — sourcing, prototyping, iteration, first revenue — can happen here in months.
For international startups approaching commercialization, we open access to China's supply chain, engineering capabilities, and real-world application scenarios — shortening the path from prototype to production, and from technology to revenue.
For established companies with proven products but no local channels, we identify the right Chinese industrial partners, land a first demonstration project, and replicate rapidly once the model is proven. From zero to one, then one to many.
2. Taking Chinese Technology Global
Entering the other stack is not a shipping problem — it is a trust problem. We build that trust in three layers:
Be Seen — International Brand Building. Through our bilingual content and communications network, we build clear brand presence and industry visibility in target markets, opening doors to key local resources.
Be Trusted — Academic Endorsement. In partnership with leading overseas research institutions, we provide independent, third-party validation of technology and business models — credibility that markets and partners recognize.
Be Paid — Biopharma IP Licensing. We support Chinese biotech and pharmaceutical innovators in out-licensing and transferring intellectual property, converting R&D into overseas clinical progress and revenue.
3. Cross-border Technology Fund
Most funds invest first and hope for execution. We execute first, then invest.
Nine Currents is preparing a cross-border dual-currency fund to back the companies we have already worked with on the ground — projects we have landed, models we have proven. Advisory generates the pipeline; execution de-risks it; capital scales it. This is the closed loop at the center of everything we do.
